Global Prostate Health Market Report and Forecast 2024-2032

Global Prostate Health Market Outlook

The global prostate health market size was valued at USD 38.1 billion in 2023, driven by the increasing incidence of prostate cancer across the globe. The market size is anticipated to grow at a CAGR of 9.1% during the forecast period of 2024-2032 to achieve a value of USD 83.4 billion by 2032.

Prostate Health: Introduction

The prostate is a small, rubbery gland in the male reproductive system. It is located in the pelvis, below the bladder and in front of the rectum. It is about the size of a walnut and weighs about 11 grams. The prostate's primary function is to produce the fluid that nourishes and transports sperm. This fluid, called seminal fluid, mixes with sperm from the testes to make semen. Prostate's muscles also help push semen through the urethra.

Prostate health refers to the well-being and proper functioning of the prostate gland, which is a small, walnut-sized organ located just below the bladder in men. The prostate gland plays a crucial role in the male reproductive system by producing seminal fluid, which nourishes and transports sperm during ejaculation.

Global Prostate Health Market Analysis

The growth of the global market for prostate health is driven by the increasing numbers of FDA approvals for new drugs targeted at addressing various aspects of prostate health. For example, approval of the fixed-dose combination of niraparib and abiraterone acetate for patients with certain types of prostate cancer, offering new treatment options is a major step and hope for new and effective treatment for prostate cancers. The market is also driven by the heavy investments by the leading key players. Increasing investments and funding in prostate health research and treatment innovations are also market trends influencing the global prostate health market growth. Researchers have been exploring novel therapies that show promising results in treating prostate cancer, even in cases where existing treatments have proven ineffective. These innovations bring hope to those patients who are suffering from the disease and offer potential innovation in prostate cancer management. Increasing efforts to reduce harm from prostate cancer screening are also accountable for the market growth.

Additionally, strategic mergers and acquisitions among key players in the healthcare industry are also contributing to the market growth. Collaborative efforts, such as the merger between Pfizer Inc. and Seagen Inc., demonstrate a concerted effort to combat cancer and develop transformative therapies. These partnerships are expected to further propel the prostate health market growth.

Global Prostate Health Market Segmentations

Market by Treatment Type

• Hormonal Therapy

• Chemotherapy

• Surgical Treatments
  • Radical Prostatectomy
  • Orchidectomy
  • Trans Urethral Resection
  • Others

• Other Treatment Types

Market Breakup by Indications

• Benign Prostatic Hyperplasia (BPH)

• Prostatitis

• Prostate Cancer

• Others

Market Breakup by Age Group

• Adults

• Geriatrics

• Others

Market Breakup by End User

• Hospitals and Clinics

• Speciality Clinics

• Homecare Settings

• Others

Market Breakup by Region

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East and Africa

Global Prostate Health Market Overview

The growth of global prostate health market growth is driven by several key factors including prostate cancer being the second most common cancer in men worldwide, highlighting the quick need for effective treatments and diagnostics. The growing prevalence of benign prostatic hyperplasia (BPH), a common condition among aging men, further contributes to the market's expansion. The increasing geriatric population acts as a major factor driving the market growth as well. The emergence of new treatment therapies and techniques for prostate cancer holds promise in improving patient outcomes and potential to drive market growth. Rapid growth in the availability of biomarker testing, allowing for early detection and more precise treatment decisions also collectively accountable for the market growth. Investments in research and development, coupled with a surge in upcoming pipeline medicines and the availability of innovative prostate treatments, are propelling the global prostate health market growth.

Geographically, North America is leading the regional market for prostate health, and it is expected to lead the market for the forecast period as well. The prevalence of prostate diseases, including prostate cancer in the region is also increasing, which is driving the market growth. The increased investment in research and development, the promising pipeline of medicines, and the availability of novel prostate health solutions collectively contribute to the market growth.

Global Prostate Health Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Abbott

• Novartis AG

• Teleflex

• AstraZeneca PLC

• Bayer AG

• Sanofi

• Pfizer

• Clovis Oncology

• Siemens Healthcare GmbH

• Elekta

Key Highlights of the Report